Back to company

Pharmaforce ApS: Financial statements 2020

CVR: 26394198

Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 4,304,738 and a net result of DKK 1,080,798 compared with DKK 263,539 the year before. That is an increase of 53% compared with the year before. Equity amounted to DKK 2,507,882. The solvency ratio was 40.8%. The company had 5 employees in the financial year.

Gross Profit
4,304,738 kr.
Profit/Loss
1,080,798 kr.
Equity
2,507,882 kr.
Total Assets
6,139,265 kr.
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-4.3 mio.1.1 mio.2.5 mio.5
2019-2.8 mio.264 t.1.4 mio.4
2018-3.7 mio.1.2 mio.2.2 mio.3
2017-2.3 mio.826 t.986 t.2
2016-1.1 mio.-74 t.161 t.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharmaforce ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Pharmaforce ApS: The 2019 annual report is outMay 12, 2020

Pharmaforce ApS has published its annual report for 2019. Gross profit came to DKK 2,813,985, and the net result was DKK 263,539.

Pharmaforce ApS appoints new auditorMay 11, 2020

As of May 11, 2020, Algade Revision - Godkendte revisorer ApS has been appointed auditor of Pharmaforce ApS.

About Pharmaforce ApS

Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.